Dr. Madhuri Devi Gadiyaram, MD

Dr. Gadiyaram practices at Robert Wood Johnson University Hospital Rahway in Rahway, New Jersey, part of RWJBarnabas Health.

Dr. Gadiyaram's NPI, 1356492433, was assigned on January 15, 2007. Dr. Gadiyaram holds New Jersey license 25MA09756200.

Dr. Gadiyaram's primary practice is Robert Wood Johnson University Hospital Rahway, at 865 Stone St, Rahway, NJ 07065 in Union County. The practice phone is (732) 381-4200.

Dr. Gadiyaram's primary practice is Robert Wood Johnson University Hospital Rahway in Rahway, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Gadiyaram to 1 more hospital, 4 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gadiyaram practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gadiyaram's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Gadiyaram's licenses on file in 2 states: New Jersey and New York.

CMS data shows 1,166 Medicare services from Dr. Gadiyaram across 4 procedure codes in 2024, for 372 Medicare patients. Medicare paid $116,708 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 372 Medicare patients who saw Dr. Gadiyaram in 2024. The largest group is 85 and over, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gadiyaram's median patient age at 70, with 48% women.

In 2024, Dr. Gadiyaram wrote 679 Medicare Part D claims for 173 patients. 85% of them were for generic drugs. CMS names the drug for 328 of them, across 18 drugs with 11 or more claims each, at $13,171 in total drug cost. In 2023, CMS named 151 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gadiyaram for performance year 2024, reported as part of a group. Dr. Gadiyaram accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gadiyaram as offering telehealth.